SHNX.Y Stock Overview
Through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Shandong Xinhua Pharmaceutical Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$18.19 |
| 52 Week High | HK$18.19 |
| 52 Week Low | HK$18.19 |
| Beta | 0.095 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| SHNX.Y | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.1% | 1.0% |
| 1Y | n/a | 13.6% | 27.2% |
Return vs Industry: Insufficient data to determine how SHNX.Y performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how SHNX.Y performed against the US Market.
Price Volatility
| SHNX.Y volatility | |
|---|---|
| SHNX.Y Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: SHNX.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine SHNX.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 6,540 | n/a | www.xhzy.com |
Shandong Xinhua Pharmaceutical Company Limited, through its subsidiaries, develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products. It operates through Chemical bulk drugs, Preparations, and Chemical intermediates and Others segments. The company offers active pharmaceutical ingredients, pharmaceutical preparations, and chemical products, such as antipyretic analgesics; drugs for cardiovascular and cerebrovascular diseases; anti-infectives; drugs for diseases related to the central nervous system; and other drugs under the Xinhua brand.
Shandong Xinhua Pharmaceutical Company Limited Fundamentals Summary
| SHNX.Y fundamental statistics | |
|---|---|
| Market cap | US$2.00b |
| Earnings (TTM) | US$51.78m |
| Revenue (TTM) | US$1.03b |
10.6x
P/E Ratio0.5x
P/S RatioIs SHNX.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SHNX.Y income statement (TTM) | |
|---|---|
| Revenue | CN¥7.07b |
| Cost of Revenue | CN¥5.30b |
| Gross Profit | CN¥1.77b |
| Other Expenses | CN¥1.41b |
| Earnings | CN¥356.66m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
Mar 24, 2023
| Earnings per share (EPS) | 0.53 |
| Gross Margin | 25.02% |
| Net Profit Margin | 5.04% |
| Debt/Equity Ratio | 22.9% |
How did SHNX.Y perform over the long term?
See historical performance and comparison